Cited by 50Mesenchymal stem cell researchMicroRNA in disease regulationExtracellular vesicles in disease

Role of microRNA 21 in mesenchymal stem cell (MSC) differentiation: a powerful biomarker in MSCs derived cells

Sekar, Durairaj, Saravanan, Subramanian, Karikalan, Kulandaivelu, Thirugnanasambantham, Krishnaraj, Lalitha, Perumal, Islam, Villianur·2015·Current Pharmaceutical Biotechnology

Abstract

The significant role of microRNAs (miRNAs) in stem cell development has been expansively discussed in recent publications and they are noticed to be involved in post transcriptional regulation of gene expression by its affinity towards the 3'UTR of target mRNA. Since the expression of miR-21 was high in cells that were derived from MSCs, recent evidence indicates that miR-21 plays a vital role in mesenchymal stem cells (MSCs) differentiation. Despite the fact that miR-21 can be considered as a powerful biomarker for MSCs differentiation, the number of studies related to the above scenario is very limited. This review highlights the recent publications related to the importance of miR-21 specifically in differentiation of MSCs.

Integrity signals

Registry

Crossref · 10.2174/138920101601150105100851

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Still being checked.

Cited by

Sorted by citations

Authors
Sekar, D., Saravanan, S., Karikalan, K., Thirugnanasambantham, K., Lalitha, P., & Islam, V.
Affiliations
Pondicherry University (IN)
Venue
Current Pharmaceutical Biotechnology
Published
2015-01-05
Volume
16
Issue
1
Pages
43-48
ISSN
1389-2010 (ISSN-L)
OpenAlex
W2146273396
Cited by
50
References
0
Citations by year
2026: 2 · 2025: 22 · 2024: 2 · 2023: 1 · 2021: 1 · 2020: 3 · 2019: 3 · 2018: 5 · 2017: 3 · 2016: 7 · 2015: 1
FWCI
2.99
Type
journal article
Language
en
Open access
closed
Locations
  • Current Pharmaceutical Biotechnology (publishedVersion)
  • PubMed (publishedVersion)
Funders
Directorate for Biological Sciences
Topics
  • Health Sciences › Medicine › Genetics › Mesenchymal stem cell research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
Keywords
miR-21, mesenchymal stem cells, stem cell differentiation, biomarkers, post-transcriptional regulation, 3' untranslated region, microRNA expression
MeSH terms
Animals, Cell Differentiation, Humans, Biomarkers, MicroRNAs, Mesenchymal Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review